Diaceutics PLC - Belfast-based provider of diagnostic commercialisation services to pharmaceutical and biotechnology companies - Opens new US headquarters in Newport, New Jersey. Says the new office is close to most of its life science customers in the northeastern US. The US market represents 90% of its revenue. The company says it will expand its US sales and marketing operations.

Vice President Chief of Staff Madeline Brown said: ‘The US market is crucial to our future growth plans and we are excited to continue to grow our business and presence in the US. In 2024, we have had significant success recruiting senior US based sales and management personnel, and opening our US HQ enables us to deepen our partnerships with US based life science customers.’

Current stock price: 147.90 pence, up 1.3% in London on Tuesday afternoon

12-month change: up 75%

Copyright 2025 Alliance News Ltd. All Rights Reserved.